“…Brazil, like other developing countries, still imports a large volume of drugs and pharmaceutical ingredients from different regions of the world, which makes the health risk greater and requires the strengthening of the national regulatory system to ensure safety, quality, and effectiveness of the product imported (Delphim;Kornis, 2018). The consumption of substandard, falsified (SF), and non-registered (NR) drugs is a worldwide health problem, causing the following effects: 1) serious health risk, as these products prolong illness and can even lead to death; 2) increased antimicrobial resistance and drug-resistant infections; 3) discredit upon health professionals and health systems; 4) greater distrust in the effectiveness of vaccines and medicines; 5) waste of families' and health systems' resources; 6) increase in the income of offenders and criminals, if "urgent measures are not taken to prevent, detect and respond" to the proliferation of these products around the world (WHO, 2017a(WHO, , 2017b.…”